Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2

被引:4
|
作者
Wei, Xiaohui [1 ]
Rong, Na
Liu, Jiangning [1 ]
机构
[1] Inst Lab Anim Sci, Chinese Acad Med Sci, Natl Hlth Commiss Key Lab Human Dis Comparat Med, Beijing Key Lab Anim Models Emerging & Remerging I, Beijing, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
SARS-CoV-2; animal model; adaptive immunity; cross-immune response; tissue-resident immune response; immune memory; CORONAVIRUS DISEASE 2019; T-CELL RESPONSES; CLINICAL CHARACTERISTICS; NEUTRALIZING ANTIBODIES; EFFECTOR FUNCTIONS; INFECTION; COVID-19; PROTECTS; MERS; SARS;
D O I
10.3389/fimmu.2022.993754
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The adaptive immune response induced by SARS-CoV-2 plays a key role in the antiviral process and can protect the body from the threat of infection for a certain period of time. However, owing to the limitations of clinical studies, the antiviral mechanisms, protective thresholds, and persistence of the immune memory of adaptive immune responses remain unclear. This review summarizes existing research models for SARS-CoV-2 and elaborates on the advantages of animal models in simulating the clinical symptoms of COVID-19 in humans. In addition, we systematically summarize the research progress on the SARS-CoV-2 adaptive immune response and the remaining key issues, as well as the application and prospects of animal models in this field. This paper provides direction for in-depth analysis of the anti-SARS-CoV-2 mechanism of the adaptive immune response and lays the foundation for the development and application of vaccines and drugs.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] An Overview of SARS-CoV-2 and Animal Infection
    Mahdy, Mohamed A. A.
    Younis, Waleed
    Ewaida, Zamzam
    FRONTIERS IN VETERINARY SCIENCE, 2020, 7
  • [32] A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
    Neerukonda, Sabari Nath
    Katneni, Upendra
    PATHOGENS, 2020, 9 (06):
  • [33] Ferrets are valuable models for SARS-CoV-2 research
    Ciurkiewicz, Malgorzata
    Armando, Federico
    Schreiner, Tom
    de Buhr, Nicole
    Pilchova, Veronika
    Krupp-Buzimikic, Vanessa
    Gabriel, Guelsah
    von Koeckritz-Blickwede, Maren
    Baumgaertner, Wolfgang
    Schulz, Claudia
    Gerhauser, Ingo
    VETERINARY PATHOLOGY, 2022, 59 (04) : 661 - 672
  • [34] SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects
    Li, Shiqin
    Li, Sijia
    Disoma, Cyrollah
    Zheng, Rong
    Zhou, Mei
    Razzaq, Aroona
    Liu, Pinjia
    Zhou, Yuzheng
    Dong, Zijun
    Du, Ashuai
    Peng, Jian
    Hu, Liqiang
    Huang, Jufang
    Feng, Pinghui
    Jiang, Taijiao
    Xia, Zanxian
    REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (02)
  • [35] Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
    Cromer, Deborah
    Juno, Jennifer A.
    Khoury, David
    Reynaldi, Arnold
    Wheatley, Adam K.
    Kent, Stephen J.
    Davenport, Miles P.
    NATURE REVIEWS IMMUNOLOGY, 2021, 21 (06) : 395 - 404
  • [36] SARS-CoV-2 Infection and the Newborn
    Ovali, Fahri
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [37] Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
    Paniskaki, Krystallenia
    Konik, Margarethe J.
    Anft, Moritz
    Meister, Toni L.
    Marheinecke, Corinna
    Pfaender, Stephanie
    Jaeger, Jasmin
    Krawczyk, Adalbert
    Zettler, Markus
    Dolff, Sebastian
    Westhoff, Timm H.
    Rohn, Hana
    Stervbo, Ulrik
    Witzke, Oliver
    Babel, Nina
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [38] Current understanding of T cell immunity against SARS-CoV-2
    Lu, Xiuyuan
    Yamasaki, Sho
    INFLAMMATION AND REGENERATION, 2022, 42 (01)
  • [39] SARS-CoV-2 Immunity: Review of Immune Response to Infection and Vaccination
    Ahmad, Rahnuma
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2021, 20 : S32 - S40
  • [40] Prospects for controlling future pandemics of SARS in highlights of SARS-CoV-2
    Basnet B.B.
    Basnet R.
    Panday R.
    VirusDisease, 2021, 32 (4) : 770 - 773